- Home
- MDXG vs ORIC Comparison
MDXG vs ORIC Comparison
Compare MDXG & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDXG
- ORIC
- Stock Information
- Founded
- MDXG 2006
- ORIC 2014
- Country
- MDXG United States
- ORIC United States
- Employees
- MDXG N/A
- ORIC N/A
- Industry
- MDXG Biotechnology: Pharmaceutical Preparations
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- MDXG Health Care
- ORIC Health Care
- Exchange
- MDXG Nasdaq
- ORIC Nasdaq
- Market Cap
- MDXG 1.1B
- ORIC 974.1M
- IPO Year
- MDXG N/A
- ORIC 2020
- Fundamental
- Price
- MDXG $6.94
- ORIC $10.52
- Analyst Decision
- MDXG Buy
- ORIC Strong Buy
- Analyst Count
- MDXG 1
- ORIC 10
- Target Price
- MDXG $12.00
- ORIC $17.33
- AVG Volume (30 Days)
- MDXG 439.7K
- ORIC 903.1K
- Earning Date
- MDXG 10-29-2025
- ORIC 11-11-2025
- Dividend Yield
- MDXG N/A
- ORIC N/A
- EPS Growth
- MDXG N/A
- ORIC N/A
- EPS
- MDXG 0.21
- ORIC N/A
- Revenue
- MDXG $363,774,000.00
- ORIC N/A
- Revenue This Year
- MDXG $12.68
- ORIC N/A
- Revenue Next Year
- MDXG $8.18
- ORIC N/A
- P/E Ratio
- MDXG $32.78
- ORIC N/A
- Revenue Growth
- MDXG 6.85
- ORIC N/A
- 52 Week Low
- MDXG $5.47
- ORIC $3.90
- 52 Week High
- MDXG $10.14
- ORIC $14.67
- Technical
- Relative Strength Index (RSI)
- MDXG 46.17
- ORIC 51.83
- Support Level
- MDXG $6.89
- ORIC $10.37
- Resistance Level
- MDXG $7.14
- ORIC $11.16
- Average True Range (ATR)
- MDXG 0.18
- ORIC 0.53
- MACD
- MDXG -0.04
- ORIC 0.03
- Stochastic Oscillator
- MDXG 29.55
- ORIC 46.43
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.